- Home
- HROW vs ERO Comparison
HROW vs ERO Comparison
Compare HROW & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- ERO
- Stock Information
- Founded
- HROW 1998
- ERO 2016
- Country
- HROW United States
- ERO Canada
- Employees
- HROW N/A
- ERO N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- ERO
- Sector
- HROW Health Care
- ERO
- Exchange
- HROW Nasdaq
- ERO Nasdaq
- Market Cap
- HROW 1.4B
- ERO 1.5B
- IPO Year
- HROW N/A
- ERO N/A
- Fundamental
- Price
- HROW $36.81
- ERO $20.88
- Analyst Decision
- HROW Strong Buy
- ERO Strong Buy
- Analyst Count
- HROW 7
- ERO 1
- Target Price
- HROW $68.50
- ERO $25.00
- AVG Volume (30 Days)
- HROW 804.0K
- ERO 1.2M
- Earning Date
- HROW 11-10-2025
- ERO 11-04-2025
- Dividend Yield
- HROW N/A
- ERO N/A
- EPS Growth
- HROW N/A
- ERO N/A
- EPS
- HROW N/A
- ERO 1.38
- Revenue
- HROW $227,661,000.00
- ERO $535,974,000.00
- Revenue This Year
- HROW $43.92
- ERO $64.70
- Revenue Next Year
- HROW $41.22
- ERO $31.18
- P/E Ratio
- HROW N/A
- ERO $15.54
- Revenue Growth
- HROW 47.69
- ERO 20.59
- 52 Week Low
- HROW $20.85
- ERO $9.30
- 52 Week High
- HROW $54.19
- ERO $24.48
- Technical
- Relative Strength Index (RSI)
- HROW 38.13
- ERO 51.58
- Support Level
- HROW $36.20
- ERO $20.20
- Resistance Level
- HROW $39.77
- ERO $22.13
- Average True Range (ATR)
- HROW 1.89
- ERO 0.99
- MACD
- HROW -0.40
- ERO -0.37
- Stochastic Oscillator
- HROW 9.98
- ERO 20.07
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.